Ananda Basu
Ananda Basu, M.D., MBBS, MD, FRCP, M.D., has been appointed as an associate director of the UAB Comprehensive Diabetes Center (UCDC) and will play an integral role on the center’s leadership team.
Basu has been a senior scientist in the center since 2023 when he joined UAB through the successful Strategic Recruitment Initiative of the Heersink School of Medicine and the UCDC. He was named the new principal investigator and director of the UAB NIH P30 Diabetes Research Center (DRC) in May 2025, following Dr. Tim Garvey’s 17 years of outstanding leadership in that role. As a University-Wide Interdisciplinary Research Center, the UCDC serves as the umbrella for the prestigious DRC as well as several other research programs and core facilities.
Basu’s primary academic appointment is in the Heersink School of Medicine as the S. Richardson Hill, Jr. Endowed Professor of Endocrinology in the Department of Medicine Division of Endocrinology, Diabetes and Metabolism and director of the UAB Diabetes Technology Programs. He has a secondary appointment in the School of Health Professions Department of Nutrition Sciences and is a senior scientist in the Nutrition Obesity Research Center (NORC).
Basu joined UAB from the University of Virginia at Charlottesville where he was a clinical investigator and the Harrison Professor of Medicine since 2017. Prior to UVA, Basu held several leadership positions spanning almost three decades at the Mayo Clinic in Rochester, Minnesota, where he completed his residency and fellowship training and rose to a full professor of medicine.
Basu is an expert in the development of innovative isotope modeling techniques coupled with organ balance methods to study whole body and regional metabolism and physiology in humans with and without diabetes. He has authored nearly 200 peer-reviewed publications in scientific journals and presented more than 150 scientific abstracts in national and international scientific meetings. His latest scientific paper was recently published in Diabetes, the flagship journal of the American Diabetes Association, in which he describes using novel glucagon isotopes for the first time to measure glucagon metabolism in Type 1 diabetes.
In addition to his new leadership roles with the UCDC and DRC, Basu will maintain his clinical practice within the Division of Endocrinology, Diabetes, and Metabolism while leading his clinical research.
“Dr. Ananda Basu is a wonderful addition to the UAB Comprehensive Diabetes Center leadership team,” said UCDC Director Anath Shalev, M.D. “As a world-renowned researcher, he has invaluable knowledge and expertise in using sophisticated tracer studies to study Type 1 and Type 2 diabetes in humans. His unique research acumen and clinical expertise, as well as collaborative approach to science will lead to exciting new opportunities within our multidisciplinary research environment at UCDC and across UAB.”